See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.52▲ 1.62%
← ALL page
XStocksXray
Market X-Ray report · 27 October 2026

Atlantic Lithium Ltd (ALL)

London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026

Key indicators

Last closeGBX 16.05
52-week range6.60 – 20.40
Return, 1 month / 3 months+4.9% / +3.5%
Return, 1 year / 3 years+86.6% / −18.9%
TrendUptrend
RSI (14)69
Volatility (1 year)81.1%
Worst drawdown (1 year)-41.4%
Average daily value traded19.91M GBX
Dividend yield–

Market X-Ray price-based

53/ 100 · High confidence · ahead of 50% of stocks on this exchange
Trend51
Momentum72
Stability (higher is calmer)20
Liquidity79
Income–

Five-year price chart navy: price · brown: 200-day average

2.0419.0936.1553.2070.252021-102023-022024-052025-072026-10

About the company

Atlantic Lithium is a mineral exploration and development company focused on lithium, based in Australia and operating in West Africa. Its main asset is the Ewoyaa lithium project in Ghana, where it is working to develop a hard rock lithium mine and processing operation. The company also explores for lithium and other minerals across its portfolio of tenements in Ghana and Ivory Coast. Its customers would be participants in the battery and electric vehicle supply chain that use lithium concentrates.

On this site Atlantic Lithium Ltd appears as a stock on the London Stock Exchange (UK), code ALL, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Atlantic Lithium Ltd (ALL) trades on the London Stock Exchange in UK. It last closed at GBX 16.05 on 27 October 2026.

Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,897 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 86.6% and over the last three months it rose 3.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Atlantic Lithium Ltd (ALL)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend51 · FairMixed trend against its averages.
Above 200-day average5.3%
From 52-week high-16.5%
Momentum72 · StrongRising faster than most stocks on this exchange.
3-month return3.5%
6-month return4.2%
12-month return, skipping the last month77.9%
Stability (higher is calmer)20 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)81.1%
Worst drawdown, 1 year (smaller is calmer)-41.4%
Liquidity79 · StrongTrades actively.
Average daily value traded19.91M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+12.2%
1 month+4.9%
3 months+3.5%
6 months+4.2%
1 year+86.6%
3 years−18.9%
5 years−13.2%

Signals

50-day / 200-day average14.76 / 15.24
Golden / death cross (60 days)Death, 12 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.70

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026